Lloyd Price

NOVEMBER 25, 2023

This is due to a number of factors, including: The increasing prevalence of chronic diseases The rising cost of healthcare The increasing demand for patient-centered care As a result, DTx companies are still expected to be attractive targets for M&A deals. The average deal size for DTx M&A deals is increasing.

Pharmaceuticals 67

Pharmaceuticals Pain management Chronic pain management Mental health 67

Lloyd Price

FEBRUARY 18, 2024

They might target smaller, innovative companies with niche solutions or complementary technologies at reasonable valuations. Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making.

Pharmaceuticals 64

Pharmaceuticals healthcare technology Digital Health Remote care 64

Lloyd Price

MAY 6, 2023

The largest funding rounds in 2018 went to companies working on healthcare technology solutions such as Rhythm Pharmaceuticals, which raised $151 million, and Modernizing Medicine, which raised $231 million. Another challenge that Olive AI has faced is increased competition in the healthcare technology space.

Digital Health 95

Digital Health Mental health Telemedicine healthcare technology 95

Healthcare IT News - Telehealth

MAY 6, 2020

The CAM Patch can serve as a remote patient monitoring system during the COVID-19 pandemic, the vendor said. Biofourmis’ digital therapeutics are used for RPM across three primary healthcare stakeholder groups: health systems, payers and pharmaceutical companies.

Connected Health 183

Connected Health Telehealth Pharmaceuticals EHR 183